Unknown

Dataset Information

Molnupiravir in COVID-19: A systematic review of literature.


ABSTRACT:

Background and aims

Molnupiravir is a newer oral antiviral drug that has recently been tested in COVID-19. We aim to conduct a systematic review of literature to find out the efficacy and safety of molnupiravir in patients with COVID-19.

Methods

We systematically searched the electronic database of PubMed, MedRxiv and Google Scholar from inception until October 15, 2021, using MeSH keywords. Ongoing trials of molnupiravir in COVID-19 were additionally searched from the ClinicalTrials.Gov and ctri.nic.in/Clinicaltrials. We retrieved all the available granular details of phase 1 to 3 studies of molnupiravir in COVID-19. Subsequently we reviewed the results narratively.

Results

Two phase 1 double-blind, randomized, placebo-controlled (DBRPC) studies of molnupiravir showe

SUBMITTER: Singh AK 

PROVIDER: S-EPMC8556684 | biostudies-literature | 2021 Nov-Dec

REPOSITORIES: biostudies-literature